Autophagy as a targeted therapeutic approach for skin cancer: Evaluating natural and synthetic molecular

Md Liakot Ali1,2, Amdad Hossain Roky2,3, S M Asadul Karim Azad2,3

  • 1Department of Pharmacy, University of Chittagong, Chattogram 4331, Bangladesh.

PubMed

Insights

Targeting autophagy, a cellular process, shows promise for skin cancer treatment. Modulators are effective and safe, offering new therapeutic avenues for this prevalent malignancy.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Skin cancer is a widespread malignancy with increasing incidence.
  • Autophagy, a cellular degradation process, plays a dual role in skin cancer development and progression.
  • Modulating autophagy presents significant therapeutic potential for skin cancer treatment.

Purpose of the Study:

  • To systematically review the relationship between skin cancer and autophagy.
  • To investigate the contribution and mechanisms of autophagy modulators in skin cancer.
  • To evaluate the effectiveness and safety of autophagy modulation as a therapeutic strategy.

Main Methods:

  • Systematic literature review.
  • Analysis of existing research on autophagy modulators in skin cancer.
  • Elucidation of physiological mechanisms of action for identified compounds.

Main Results:

  • A diverse range of autophagy modulators show promise for skin cancer treatment.
  • Each compound acts through distinct, elucidated physiological mechanisms.
  • No notable adverse effects were reported for natural, synthetic, or semisynthetic compounds in human or animal models.

Conclusions:

  • Targeting autophagy is a promising therapeutic strategy for skin cancer.
  • Autophagy modulators offer novel mechanistic and therapeutic perspectives.
  • The safety profile of these modulators suggests a viable clinical approach.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K